Association of Hyaluronic Acid-Enriched Transfer Medium (HETM) with Clinical Pregnancy Outcome in Women Undergoing Frozen-Thawed Embryo Transfer (FET)

透明质酸富集移植培养基(HETM)与接受冷冻-解冻胚胎移植(FET)女性临床妊娠结局的关系

阅读:1

Abstract

BACKGROUND: Recurrent implantation failure is one of the most important problems in the assisted reproduction technologies, such as women who want frozen-thawed embryo transfers. Improvements in embryo culture and transfer techniques notwithstanding, success rates for both implantation and clinical pregnancy remain suboptimal for many patients, especially those with repeated implantation failure. In improving the conditions of embryo transfer, therefore, this has become one of the central focuses of fertility research in trying to enhance the chances of successful implantation. OBJECTIVES: The objective of this study is to evaluate whether hyaluronic acid-enhanced transfer medium improves implantation and clinical pregnancy rates (CPR) in frozen-thawed embryo transfer cycles as compared to standard transfer medium, taking into account the effects of patient demographics, exposure duration, and ovarian stimulation protocols on outcomes. EXPECTED RESULT: Women with repeated implantation failure are anticipated to have greater rates of implantation, clinical pregnancy, and live birth when using HETM as opposed to the control group using standard transfer media. Additionally, optimal exposure durations of HETM (60 and 120 min) are anticipated to further improve outcomes. Secondary outcomes, including early pregnancy loss, multiple birth rates, and adverse pregnancy outcomes, will also be assessed. CONCLUSION: In conclusion Hyaluronic Acid-Enriched Transfer Medium (HETM) has the potential to enhance implantation rates in assisted reproduction, findings of various studies are inconsistent. Its efficacy can be influenced by patient features and treatment protocols. More studies are required to define the most favorable conditions for the application of HETM, particularly in women with recurrent implantation failure, to optimize its advantage in frozen-thawed embryo transfers.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。